Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 15, 2005 - Issue 11
Submit an article Journal homepage
69
Views
8
CrossRef citations to date
0
Altmetric
Patent Evaluation

Novel inhibitors of the type 1 transporter for glycine (GlyT1) as antipsychotic agents

Sanofi: WO2004013100, WO2004013101, WO2005037782, WO2005037783, WO2005037785 & WO2005037792

John A Lowe III Pfizer Global Research and Development, Pfizer, Inc., Eastern Point Road, Groton CT 06340, USA. [email protected]
Pages 1657-1662 | Published online: 28 Oct 2005

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.